What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug shortages and higher prices.

President Donald Trump’s sweeping tariffs on countries around the world, including a 104% levy on Chinese imports, took effect early Wednesday, dramatically altering the global trade landscape. Trump also said he will announce tariffs on pharmaceutical products “very shortly,